Therapeutic Targeting of the General RNA Polymerase II Transcription Machinery
Inhibitors targeting the general RNA polymerase II (RNAPII) transcription machinery are candidate therapeutics in cancer and other complex diseases. Here, we review the molecular targets and mechanisms of action of these compounds, framing them within the steps of RNAPII transcription. We discuss th...
Main Authors: | Ryan D. Martin, Terence E. Hébert, Jason C. Tanny |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/9/3354 |
Similar Items
-
Targeting General Transcriptional Machinery as a Therapeutic Strategy for Adult T-Cell Leukemia
by: Regina Wan Ju Wong, et al.
Published: (2018-05-01) -
Novel CDKs inhibitors for the treatment of solid tumour by simultaneously regulating the cell cycle and transcription control
by: Xin Wang, et al.
Published: (2020-01-01) -
Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism
by: Huasong Lu, et al.
Published: (2015-06-01) -
Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment
by: Ni Made Pitri Susanti, et al.
Published: (2021-07-01) -
Targeting cell cycle regulators in hematologic malignancies
by: Eiman eAleem, et al.
Published: (2015-04-01)